CW June 2004
Volume 13Issue Number 6 June 2004 ISSN 10593802 Chemotherapy-induced Cognitive DysfunctionChemotherapy-induced neurocognitive dysfunctions observed in cancer patients may not be a side effect of the regimen in all cases. Over 30% of breast cancer patients in a study showed neurocognitive impairment before the start of adjuvant chemotherapy.
Go to Previous Page Go to Next Page Source & Additional Reading C. A. Meyers et al., Cancer, June 21, 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
